Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Health Economics Review

Table 2 Input parameters and values used in the economic model

Input parameters	Value	Source
One-year decision tree
*Ticagrelor*
No event	0.894	PLATO [7], Nikolic [8]
Non-fatal MI	0.050	PLATO [7], Nikolic [8]
Non-fatal stroke	0.010	PLATO [7], Nikolic [8]
Death any cause	0.046	PLATO [7], Nikolic [8]
*Clopidogrel*
No event	0.875	PLATO [7], Nikolic [8]
Non-fatal MI	0.057	PLATO [7], Nikolic [8]
Non-fatal stroke	0.009	PLATO [7], Nikolic [8]
Death any cause	0.059	PLATO [7], Nikolic [8]
Markov model ^a
Annual risk of MI in the no event state	0.019	PLATO [7], Nikolic [8]
Annual risk of stroke in the no event state	0.003	PLATO [7], Nikolic [8]
Risk of death in no event state^b	2.000	Thai Life table [10], Allen [11], Taneja [12]
Risk of death in the non-fatal MI state^b	6.000	PLATO [7], Nikolic [8]
Risk of death in the post MI state^b	3.000	PLATO [7], Nikolic [8]
Risk of death in the non-fatal stroke state^b	7.430	Dennis [13], Hanke [14]
Risk of death in the post stroke state^b	3.000	PLATO [7], Nikolic [8]

ISSN: 2191-1991